atelocollagen

  • 文章类型: Journal Article
    A meeting of Interdisciplinary Expert Panel with leading specialists in the field of orthopedics/traumatology, surgery, rheumatology, and neurology was held in Moscow on February 10, 2023. The purpose of the meeting was to discuss the current status of local injection therapy (LIT) in Russia and the rationale behind the use of collagen-based products for various musculoskeletal disorders. The experts considered the following issues: (1) General contraindications to the use of medical products based on tropocollagen as well as an algorithm for actions in case of adverse events; (2) Guidelines regarding LIT in general and LIT using tropocollagen in particular, including in combination with other LIT products; (3) Particular indications and approaches to the treatment of patients with abnormal changes in appendicular joints and spine with damage to both intra-articular structures and periarticular soft tissue.
    10 февраля 2023 г. в Москве состоялся междисциплинарный Совет экспертов с ведущими специалистами в области ортопедии-травматологии, хирургии, ревматологии, неврологии. Целью заседания было обсуждение текущей ситуации, связанной с состоянием локальной инъекционной терапии в России, и актуальности применения препаратов на основе коллагена при разнообразной патологии опорно-двигательного аппарата. Экспертами рассмотрены следующие вопросы: 1) общие противопоказания к использованию медицинских изделий на основе тропоколлагена, а также алгоритм действий при возникновении нежелательных явлений; 2) общие положения относительно локальной инъекционной терапии (ЛИТ) вообще и ЛИТ с использованием тропоколлагена в частности, в том числе в комбинации с другими ЛИТ-средствами; 3) частные показания и подходы к лечению пациентов с патологическими изменениями суставов конечностей и позвоночника в рутинной практике при поражении как внутрисуставных структур, так и околосуставных мягких тканей.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景/目的:Atelocollagen用于软组织修复和重建,通过替换有缺陷或受损的肌肉,膜,韧带,和肌腱。这项研究旨在评估在腰椎硬膜外类固醇注射中额外的椎旁肌内注射atelocollagen的临床疗效和安全性,以减轻疼痛并改善慢性下腰痛(CLBP)患者的功能。方法:我们回顾性招募了608例连续的CLBP患者,这些患者接受了腰椎硬膜外类固醇注射,或没有额外的椎旁肌内注射骨胶原。使用数字评定量表和Oswestry残疾指数评估疼痛和功能能力,分别,在程序之前,注射后三个月。此外,我们分析了额外的椎旁肌内注射ateloclagen与成功率之间的关系。结果:注射后三个月,两组的数字评定量表和Oswestry残疾指数评分均显着降低。然而,两组之间有显著差异。此外,额外椎旁肌内注射去端胶原组的成功率明显较高。结论:这项研究的结果表明,在腰椎硬膜外类固醇注射的基础上,额外的椎旁肌内注射去胶原减轻了CLBP患者的疼痛并改善了功能能力。因此,椎旁肌内注射去胶原可能是CLBP患者治疗的一个有前景的选择.
    Background/Objectives: Atelocollagen is used for soft tissue repair and reconstruction by replacing defective or damaged muscles, membranes, ligaments, and tendons. This study aimed to evaluate the clinical efficacy and safety of additional paraspinal intramuscular injection of atelocollagen on lumbar epidural steroid injection for reducing pain and improving functional capacity of patients with chronic low back pain (CLBP). Methods: We retrospectively enrolled 608 consecutive patients with CLBP who received lumbar epidural steroid injection with or without additional paraspinal intramuscular injection of atelocollagen. The Numerical Rating Scale and the Oswestry Disability Index were used to assess pain and functional capacity, respectively, before the procedure, and three months after the injection. Also, we analyzed the relationship between the additional paraspinal intramuscular injection of atelocollagen and the success rate. Results: Both Numerical Rating Scale and the Oswestry Disability Index scores were significantly reduced in both groups at three months after injection. However, there was a significant difference between the two groups. Furthermore, the success rate was significantly higher in the additional paraspinal intramuscular injection of atelocollagen group. Conclusions: This study\'s results showed that additional paraspinal intramuscular injection of atelocollagen on lumbar epidural steroid injection reduced pain and improved functional capacity for patients with CLBP. Therefore, the paraspinal intramuscular injection of atelocollagen may be a promising option for the treatment of patients with CLBP.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    即使关节镜肩袖修复被认为是一种标准治疗选择,术后撕裂的风险是一个主要问题。
    评价猪来源的可吸收斑片型去骨胶原在关节镜肩袖修复中的作用。
    随机对照试验;证据水平,1.
    从2020年11月至2021年12月,前瞻性纳入了64例经磁共振成像(MRI)诊断的肩袖撕裂患者。两组均使用缝合桥技术进行了修复。对于去胶原组,在固定侧锚之前,我们在足印和肌腱之间插入了猪来源的可吸收斑贴型去端胶.术后第2天,患者接受MRI检查以确认斑块型骨胶原的容纳。术后6个月和1年,使用MRI评估修复肌腱的信号强度.使用Constant评分作为主要结果对患者进行评估,以及疼痛的视觉模拟量表;活动范围;美国肩肘外科医生评分;加州大学,洛杉矶,评分;以及术前和术后2、3、6和12个月的韩国肩关节评分。
    作为主要结果的Constant评分没有显著变化,疼痛或其他功能评分,术后1年观察组间的活动范围。术后2天进行的零时间MRI扫描证实了包含贴片型骨胶原。在最终分析的55名患者中,记录了12例再撕裂(21.8%的再撕裂率)。在前胶原组中发现了明显较低的再撕裂率,本组3例(10.3%),常规修复组9例(34.6%)(P=.048)。
    两组之间的Constant评分没有差异。与常规组相比,接受猪源可吸收斑片型前胶原的肩袖修复后的再撕裂率显着降低。
    KCT0005184(临床研究信息服务[CRIS];https://cris.nih.走吧。kr)。
    UNASSIGNED: Even though arthroscopic rotator cuff repair is recognized as a standard treatment option, the risk of postoperative retear is a major concern.
    UNASSIGNED: To evaluate the effect of porcine-derived absorbable patch-type atelocollagen during arthroscopic rotator cuff repair.
    UNASSIGNED: Randomized controlled trial; Level of evidence, 1.
    UNASSIGNED: A total of 64 patients with rotator cuff tears diagnosed on magnetic resonance imaging (MRI) were enrolled prospectively from November 2020 to December 2021. Both groups had repairs using the suture bridge technique. For the atelocollagen group, before securing the lateral anchors, we inserted porcine-derived absorbable patch-type atelocollagen between the footprint and the tendon. On postoperative day 2, the patients underwent MRI to confirm containment of the patch-type atelocollagen. At 6 months and 1 year postoperatively, the signal intensity of the repaired tendon was assessed using MRI. Patients were evaluated using the Constant score as the primary outcome, along with the visual analog scale for pain; range of motion; American Shoulder and Elbow Surgeons score; University of California, Los Angeles, score; and Korean Shoulder Score preoperatively and at 2, 3, 6, and 12 months postoperatively.
    UNASSIGNED: No significant changes in the Constant score as primary outcome, pain or other functional scores, and range of motion were observed between the groups at 1 year postoperatively. The patch-type atelocollagen was confirmed to be contained by the time-zero MRI scan taken 2 days postoperatively. Among the 55 patients included in final analysis, 12 retear cases were recorded (21.8% retear rate). A significantly lower retear rate was found in the atelocollagen group, as 3 cases were observed in this group (10.3%) and 9 cases were observed in the conventional repair group (34.6%) (P = .048).
    UNASSIGNED: The Constant score was not different between the groups. The retear rate after rotator cuff repair was significantly lower in the group that received porcine-derived absorbable patch-type atelocollagen compared with in the conventional group.
    UNASSIGNED: KCT0005184 (Clinical Research Information Service [CRIS]; https://cris.nih.go.kr).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究的目的是通过免疫组织化学分析研究再生过程,并评估局部应用BDNF治疗发炎的3壁骨内缺损后的牙周组织再生。
    背景:脑源性神经营养因子(BDNF)在中枢和外周神经元的存活和分化中起作用。BDNF可以调节非神经细胞的功能,成骨细胞,牙周膜细胞,内皮细胞,以及神经细胞。我们先前的研究表明,局部应用BDNF可以增强狗实验性牙周缺损中的牙周组织再生,并且BDNF可以刺激骨(牙骨质)相关蛋白的表达和人牙周膜细胞的增殖。
    方法:拔除下颌第一和第三前磨牙六周后,在比格犬的下颌第二和第四前磨牙中产生了3壁骨内缺损。将印模材料放置在所有人工缺损中以诱导炎症。第一次手术两周后,将浸入去端胶海绵中的BDNF(25和50μg/mL)应用于缺损。作为一种控制,仅使用浸入盐水中的atelocollagen海绵。BDNF应用后两周和四周,进行形态计量学分析.通过免疫组织化学分析评估骨桥蛋白(OPN)和增殖细胞核抗原(PCNA)阳性细胞的定位。
    结果:应用BDNF后两周,牙周组织部分再生。免疫组织化学分析显示,裸露根表面的细胞OPN和PCNA阳性。在再生牙周组织的软结缔组织中也检测到PCNA阳性细胞。应用BDNF后四周,牙骨质再生牙周缺损,牙周膜,和牙槽骨。沿着根表面,观察到丰富的OPN阳性细胞。形态学分析表明,实验组的新骨水泥长度百分比和新骨面积百分比高于对照组,并呈剂量依赖性增加。
    结论:这些发现表明,BDNF可以通过刺激牙周膜细胞增殖并分化为牙周组织细胞,从而在再生早期诱导牙骨质再生。导致发炎的3壁骨内缺损的牙周组织再生增强。
    OBJECTIVE: The purpose of this study is to investigate regenerative process by immunohistochemical analysis and evaluate periodontal tissue regeneration following a topical application of BDNF to inflamed 3-wall intra-bony defects.
    BACKGROUND: Brain-derived neurotrophic factor (BDNF) plays a role in the survival and differentiation of central and peripheral neurons. BDNF can regulate the functions of non-neural cells, osteoblasts, periodontal ligament cells, endothelial cells, as well as neural cells. Our previous study showed that a topical application of BDNF enhances periodontal tissue regeneration in experimental periodontal defects of dog and that BDNF stimulates the expression of bone (cementum)-related proteins and proliferation of human periodontal ligament cells.
    METHODS: Six weeks after extraction of mandibular first and third premolars, 3-wall intra-bony defects were created in mandibular second and fourth premolars of beagle dogs. Impression material was placed in all of the artificial defects to induce inflammation. Two weeks after the first operation, BDNF (25 and 50 μg/mL) immersed into atelocollagen sponge was applied to the defects. As a control, only atelocollagen sponge immersed in saline was applied. Two and four weeks after the BDNF application, morphometric analysis was performed. Localizations of osteopontin (OPN) and proliferating cell nuclear antigen (PCNA)-positive cells were evaluated by immunohistochemical analysis.
    RESULTS: Two weeks after application of BDNF, periodontal tissue was partially regenerated. Immunohistochemical analyses revealed that cells on the denuded root surface were positive with OPN and PCNA. PCNA-positive cells were also detected in the soft connective tissue of regenerating periodontal tissue. Four weeks after application of BDNF, the periodontal defects were regenerated with cementum, periodontal ligament, and alveolar bone. Along the root surface, abundant OPN-positive cells were observed. Morphometric analyses revealed that percentage of new cementum length and percentage of new bone area of experimental groups were higher than control group and dose-dependently increased.
    CONCLUSIONS: These findings suggest that BDNF could induce cementum regeneration in early regenerative phase by stimulating proliferation of periodontal ligament cells and differentiation into periodontal tissue cells, resulting in enhancement of periodontal tissue regeneration in inflamed 3-wall intra-bony defects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    一种由脱胶原组成的坚韧凝胶,缺乏免疫基因位点,是生物医学应用的一种有前途的材料。在这项研究中,我们创建了由戊二醛(GA)和聚(N,N-二甲基丙烯酰胺)凝胶具有基于双网络(DN)凝胶原理的生物相容性。无论使用的交联剂(GA)的量如何,脱胶原凝胶的拉伸韧性都保持恒定。相比之下,DN凝胶的拉伸试验表明,机械性能,如断裂应力和韧性,明显高于atelocolagen凝胶。此外,成纤维细胞粘附并扩散在凝胶上,其席夫碱通过还原胺化处理以从GA中解毒。这些发现证明了所提出的凝胶材料作为具有亚MPa断裂应力的软组织的人工替代材料的潜力。
    A tough gel composed of atelocollagen, which lacks an immunogenetic site, is a promising material for biomedical application. In this study, we created a composite hydrogel composed of atelocollagen gel cross-linked with glutaraldehyde (GA) and poly-(N,N-dimethylacrylamide) gel exhibiting biocompatibility based on the double-network (DN) gel principle. The tensile toughness of atelocollagen gel remained constant regardless of the amount of cross-linker (GA) used. In contrast, tensile tests of the DN gel indicated that mechanical properties, such as fracture stress and toughness, were significantly higher than those of the atelocollagen gel. Moreover, fibroblast cells adhered and spread on the gels, the Schiff bases of which were treated via reductive amination for detoxification from GA. These findings demonstrate the potential of the proposed gel materials as artificial alternative materials to soft tissues with sub-MPa fracture stress.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:Atelocollagen(AC)是一种低免疫原性的胶原蛋白衍生物,降解时间更长,这可以是一个合适的材料牙槽的保存(ARP)。然而,很少有人类研究将AC用于ARP。这项研究旨在通过影像学评估与ARP中覆盖有胶原蛋白膜(DBBM/CM)的脱蛋白牛骨矿物质相比,AC的功效。
    方法:在武汉大学口腔医院种植科的病历中,使用AC或DBBM/CM筛查接受无舌ARP的患者。本回顾性研究共纳入58例患者。28例患者接受AC治疗,30例患者使用DBBM/CM。在拔除前和愈合6个月后进行锥形束计算机断层扫描(CBCT)扫描。要评估提取插座的尺寸变化,将扫描数据输出并传输到数字软件以测量水平骨宽度变化,感兴趣区域的垂直骨高度变化和骨体积变化。为了评估愈合的窝的骨质量,评估虚拟植入物的骨密度。
    结果:在所有五个不同水平上的水平骨宽度变化在两组之间均无显着差异。两组最大的水平骨宽度衰减发生在山脊处,AC组下降3.71±1.67mm,DBBM/CM组下降3.53±1.51mm(p=0.68)。在中颊方面,AC组山脊高度降低0.10±1.30mm,而DBBM/CM组增加0.77±2.43mm(p=0.10)。两组间垂直骨高度差异无统计学意义。AC组和DBBM/CM组的体积吸收百分比分别为12.37%±6.09%和14.54%±11.21%。分别。没有发现体积吸收的显著差异(p=0.36)。AC组虚拟种植体周围的平均骨密度(649.41±184.71HU)明显低于DBBM/CM组(985.23±207.85HU)(p<0.001)。
    结论:ARP与AC对限制牙槽嵴的尺寸改变具有相似的作用,当射线照相与DBBM/CM比较时。
    Atelocollagen (AC) is a low-immunogenic collagen derivative with longer degradation time, which can be a suitable material for alveolar ridge preservation (ARP). However, there are few human studies on AC using for ARP. This research aims to radiographically evaluate the efficacy of AC in comparison to deproteinized bovine bone minerals covered with a collagen membrane (DBBM/CM) in ARP.
    Medical records in the Implantology Department of the Hospital of Stomatology of Wuhan University were screened for patients who received flapless ARP using either AC or DBBM/CM. A total of 58 patients were included in this retrospective study. 28 patients were treated with AC, while 30 patients were used DBBM/CM. Cone-beam computed tomography (CBCT) scans were taken before extraction and after 6 months of healing. To assess the dimensional change of the extraction sockets, the scanning data were output and transferred to the digital software to measure horizontal bone width change, vertical bone height change and bone volume change in region of interest. To evaluate the bone quality of healed sockets, the bone density of virtual implants was evaluated.
    The horizontal bone width changes at all five different levels showed no significant difference between the two groups. The largest horizontal bone width decrement in both groups occurred at the crest of ridge, which decreased 3.71 ± 1.67 mm in AC group and 3.53 ± 1.51 mm in DBBM/CM group (p = 0.68). At the central buccal aspect, the ridge height reduced 0.10 ± 1.30 mm in AC group, while increased 0.77 ± 2.43 mm in DBBM/CM group (p = 0.10). The vertical bone height differences between two groups showed no statistical significance. The percentages of volume absorption in AC group and DBBM/CM group were 12.37%±6.09% and 14.54%±11.21%, respectively. No significant difference in volume absorption was found (p = 0.36). The average bone density around virtual implants in AC group (649.41 ± 184.71 HU) was significantly lower than that in DBBM/CM group (985.23 ± 207.85 HU) (p < 0.001).
    ARP with AC had a similar effect on limiting the dimensional alteration of alveolar ridge, when radiographically compared with DBBM/CM.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    对于跟腱断裂(ATR)的非手术治疗越来越感兴趣。然而,非手术治疗受到肌腱断裂风险和低满意率的限制.最近,据报道,注射atelocollagen对肌腱愈合有有益作用。
    评价注射前胶原对跟腱愈合的有益作用,探讨前胶原对腱愈合的作用机制。
    对照实验室研究。
    对66只大鼠进行了右跟腱的经皮肌腱切开术。将动物平均分为非注射组(NG)和胶原注射组(CG)。在第1、3和6周,跟腱功能指数,横截面积,负载失效,刚度,压力,并评估了改良的Bonar评分。透射电子显微镜,西方印迹,和免疫组织化学也进行了。
    跟腱功能指数(分别为-6.8和-43.0;P=.040),失效载荷(42.1对27.0N,分别为;P=.049),和刚度(18.8vs10.3N/mm,分别;P=.049)在3周时,CG高于NG。两组间组织学评分差异无统计学意义。透射电镜分析表明,在3周时,CG中胶原纤维的平均直径大于NG中的胶原纤维的平均直径(117.2vs72.6nm,分别为;P<.001)和6周(202.1vs144.0nm,分别;P<.001)。Westernblot分析表明,在1周(P=.005)和6周(P=.001),CG中I型胶原的表达高于NG中的表达。
    骨胶原注射对非手术治疗的跟腱损伤的愈合具有有益作用。CG大鼠的跟腱表现出更好的功能,生物力学,与NG大鼠的形态学结果比较。分子数据表明,去端胶注射的机制可能与I型胶原蛋白的增加有关。
    去端胶注射可能是非手术治疗ATR的良好辅助选择。
    UNASSIGNED: There is growing interest in nonoperative treatment for the management of Achilles tendon ruptures (ATRs). However, nonoperative treatment is limited by the risk of tendon reruptures and low satisfaction rates. Recently, atelocollagen injections have been reported to have beneficial effects on tendon healing.
    UNASSIGNED: To evaluate the beneficial effects of injected atelocollagen on Achilles tendon healing and investigate the mechanism of atelocollagen on tendon healing.
    UNASSIGNED: Controlled laboratory study.
    UNASSIGNED: Percutaneous tenotomy of the right Achilles tendon in 66 rats was performed. The animals were equally divided into the noninjection group (NG) and the collagen injection group (CG). At 1, 3, and 6 weeks, the Achilles functional index, cross-sectional area, load to failure, stiffness, stress, and the modified Bonar score were assessed. Transmission electron microscopy, western blotting, and immunohistochemistry were also performed.
    UNASSIGNED: The Achilles functional index (-6.8 vs -43.0, respectively; P = .040), load to failure (42.1 vs 27.0 N, respectively; P = .049), and stiffness (18.8 vs 10.3 N/mm, respectively; P = .049) were higher in the CG than those in the NG at 3 weeks. There were no significant differences in histological scores between the 2 groups. Transmission electron microscopy analysis showed that the mean diameter of collagen fibrils in the CG was greater than that in the NG at 3 weeks (117.2 vs 72.6 nm, respectively; P < .001) and 6 weeks (202.1 vs 144.0 nm, respectively; P < .001). Western blot analysis showed that the expression of collagen type I in the CG was higher than that in the NG at 1 week (P = .005) and 6 weeks (P = .001).
    UNASSIGNED: An atelocollagen injection had beneficial effects on the healing of nonoperatively treated Achilles tendon injuries. The Achilles tendon of CG rats exhibited better functional, biomechanical, and morphological outcomes compared with NG rats. The molecular data indicated that the mechanism of atelocollagen injections may be associated with an increased amount of collagen type I.
    UNASSIGNED: An atelocollagen injection might be a good adjuvant option for the nonoperative treatment of ATRs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:肩袖(RC)病理被认为是肩关节残疾和疼痛的最常见原因。关节镜下修复RC撕裂已被证明是一种有效的手术。不愈合和再撕裂仍然是重要的临床问题和对外科医生的挑战。此外,增强RC腱-骨愈合的必要生物增强剂仍在研究中。该研究的目的是评估在关节镜下修复全层RC泪液中注射去胶原和脱细胞真皮基质(ADM)同种异体移植物的安全性和有效性。
    方法:从2018年1月至2020年3月,共129例全厚度RC撕裂患者,仅通过关节镜修复(Ⅰ组,n=36,平均年龄=63.2岁),关节镜下修复术联合去端胶原1ml注射(Ⅱ组,n=44,平均年龄=63岁),或RC泪液与ADM同种异体移植1ml注射(Ⅲ组,n=49,平均年龄=64.6岁)。对它们进行了前瞻性研究。这项研究包括冈上肌腱大小<5cm的可修复全层撕裂的患者。我们排除了肩胛骨下肌腱孤立性撕裂的患者,那些以前做过肩部手术的人,以及那些接受任何类型注射不到六周的人。美国肩肘外科医师得分,恒定肩关节评分,视觉模拟量表疼痛评分,术前评估活动范围,在术后3、6、12个月,以及最后的后续行动。此外,在术后2个月和12个月进行磁共振成像(MRI).
    结果:平均随访时间为20个月。在最后的随访中,所有组的功能和疼痛评分均有改善,但3组疗效无明显差异(P>0.05)。两个月后,Ⅰ组无愈合率为11%(4/36),Ⅱ组4%(2/44),Ⅲ组为2%(1/49)(P>0.05)。Ⅰ组12个月后再撕裂率为19.4%(7/36),Ⅱ组13.6.7%(6/44),Ⅲ组为20.4%(10/49)(P>0.05)。在任何组中均未检测到不良事件。
    结论:我们的研究显示,与对照组相比,在12个月的随访中,关节镜下RC修复中注射异体骨胶原和同种异体ADM的临床或放射学结果未优于对照组。然而,未观察到与去端胶原和ADM同种异体移植物注射相关的不良事件.
    BACKGROUND: Rotator cuff (RC) pathologies are considered the most common cause of shoulder disability and pain. Arthroscopic repair of RC tears has proven to be an effective operation. Nonhealing and retear remain significant clinical problems and a challenge to surgeons. In addition, the essential biological augment to enhance RC tendon-bone healing is still under research. The purpose of the study was to assess the safety and efficacy of injection of atelocollagen and acellular dermal matrix (ADM) allograft in arthroscopic repair of full-thickness RC tears.
    METHODS: From January 2018 to March 2020, a total of 129 patients with full-thickness RC tear were treated by arthroscopic repair only (group 1, n = 36, with a mean age = 63.2 years), arthroscopic repair together with atelocollagen 1-mL injection (group 2, n = 44, with a mean age = 63 years), or RC tears together with ADM allograft 1-mL injection (group 3, n = 49, with a mean age = 64.6 years). They were prospectively studied. This study included patients with a repairable full-thickness tear of the supraspinatus tendon size <5 cm. We excluded patients with isolated tears of the subscapularis tendon, those with a previous shoulder surgery, and those who had any type of injection for less than 6 weeks. American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form score, Constant Shoulder score, visual analog scale pain score, and range of motion were evaluated preoperatively, at 3, 6, and 12 months of the postoperative period and the final follow-up. In addition, magnetic resonance imaging was performed at 2 months and 12 months postoperatively.
    RESULTS: The mean follow-up period was 20 months. All groups showed improvement in functional and pain score at the final follow-up; however, there is no superior outcome among the 3 groups (P > .05). After 2 months, the nonhealing rate was 11% (4 of 36) for group 1, 4% (2 of 44) for group 2, and 2% (1 of 49) for group 3 (P > .05). The retear rates after 12 months was 19.4% (7 of 36) for group 1, 13.6% (6 of 44) for group 2, and 20.4% (10 of 49) for group 3 (P > .05). Adverse events were not detected in any groups.
    CONCLUSIONS: Our study did not show superior clinical or radiologic outcomes of atelocollagen and ADM allograft injections in arthroscopic RC repair over 12 months of follow-up in comparison to the control group. However, adverse events related to atelocollagen and ADM allograft injection were not observed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    微骨折是使用骨髓成分刺激软骨再生的常见技术。然而,微骨折的临床效果从差到好。为了增强软骨愈合,已经开发了几种加固技术,包括猪源胶原支架,透明质酸,和壳聚糖。自体胶原诱导的软骨形成(ACIC)是一种用于软骨再生的单步手术技术,将凝胶型骨胶原支架与微骨折相结合。尽管ACIC是一种相对较新的技术,文献显示良好的临床效果。此外,ACIC的所有程序都是通过关节镜进行的,这在外科医生和患者中越来越受欢迎。ACIC技术也被称为Shetty-Kim技术,因为它是从A.A.Shetty和S.J.Kim的作品中开发出来的。这是对ACIC历史的最新回顾。
    Microfracture is a common technique that uses bone marrow components to stimulate cartilage regeneration. However, the clinical results of microfracture range from poor to good. To enhance cartilage healing, several reinforcing techniques have been developed, including porcine-derived collagen scaffold, hyaluronic acid, and chitosan. Autologous collagen-induced chondrogenesis (ACIC) is a single-step surgical technique for cartilage regeneration that combines gel-type atelocollagen scaffolding with microfracture. Even though ACIC is a relatively new technique, literature show excellent clinical results. In addition, all procedures of ACIC are performed arthroscopically, which is increasing in preference among surgeons and patients. The ACIC technique also is called the Shetty-Kim technique because it was developed from the works of A.A. Shetty and S.J. Kim. This is an up-to-date review of the history of ACIC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    牙周病是牙齿脱落的主要原因之一,也是继牙周病之后第二常见的口腔疾病。自身免疫性疾病患者,比如桥本病,更容易受到感染。在研究组患者中,尽管没有其他牙龈炎的迹象,刷牙或轻微创伤后出血。探查出血是持续炎症的第一个客观迹象。这项研究是在一组17名诊断为桥本病的患者中进行的。使用用5mL0.9%NaCl稀释的去端胶原Linerase(100mg)。将总共0.05mL的溶液注射到角化的牙龈中,牙龈乳头基底上方两毫米,两周间隔四次。第一次和第二次注射前胶原后,出血点的数量减少最大。第三次和第四次注射后,平均防喷器继续下降,但是下降非常缓慢。使用去端胶可以消除研究组的出血症状。
    Periodontal diseases are one of the main causes of tooth loss and the second most common oral disease after carries. Patients with autoimmune diseases, such as Hashimoto\'s disease, are more often vulnerable to infection. In the study group of patients, despite the lack of other signs of gingivitis, bleeding occurred after tooth brushing or minor trauma. Bleeding on probing is the first objective sign of ongoing inflammation. The study was conducted on a group of 17 patients diagnosed with Hashimoto\'s disease. The atelocollagen Linerase (100 mg) thinned with 5 mL 0.9% NaCl was used. A total of 0.05 mL of solution was injected into keratinized gingiva, two millimeters above the gingival papillae basement, four times in two-week intervals. The greatest decrease in the number of bleeding points was observed after the first and second injections of atelocollagen. After the third and fourth injections, the average BOP continued to decrease, but the decline was very slow. The use of atelocollagen made it possible to eliminate bleeding symptoms in the study group.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号